INS and metabolic syndrome: The majority of T2D cases occur in the context of a metabolic syndrome leading to a chronic excess of energetic substrates and ectopic fat storage, insulin resistance, elevated levels of inflammatory cytokines and, ultimately, a decrease in insulin secretion and the apoptosis of pancreatic β cells.